Decreased expression of EBV in gingival mucosa after a treatment of two months with Ganoderma lucidum, Coriolus versicolor and Lentinus edodes (2015) Abstract A randomised single-blind study was performed to investigate the efficacy of Ganoderma lucidum+Coriolus versicolor+Lentinus edodes (GCL; 61 patients), given two months, versus placebo i.e. Laetiporus sulfureus associated with eight essential oils (LS+HE; only 1/8 drop per day; 32 patients) against the oral reactivation of EBV with detectable DNA-EBV in oral swabs. GCL decreased by 80.3% le presence of DNA-EBV in oral swabs versus 6.3% for LS+HE (p<0.001). GCL is a harmless and promising association of mycelia which could prevent EBV induced-diseases. This preliminary study should be completed in order to increase the number of inclusions and confirm this finding. Additional queries may be tackled: should prevention require prolonged therapy with reduced dosage or may GCL participate to the eradication of other viruses such as papillomavirus, HSV1, HSV2 or cytomegalovirus? Author : Dr. Bruno Donatini; gastroenterologist, hepatologist and oncologist Material : 200mg morning and evening intake of Ganodema lucidum (reishi), Coriolus versicolor (yun zhi) , Lentinus edodes (shiitake) from Mycelia company (Gent, Belgium) Has anyone with EBV had success with mushroom?